Evidence map›Paper›PMID 34575045›Full record

ArticleLife (Basel, Switzerland)2021

BNT162b2 SARS-CoV-2 Vaccination Elicits High Titers of Neutralizing Antibodies to Both B.1 and P.1 Variants in Previously Infected and Uninfected Subjects.

Ilaria Vicenti, Francesca Gatti, Renzo Scaggiante, Adele Boccuto, Daniela Zago, Monica Basso, Filippo Dragoni, Saverio Giuseppe Parisi, Maurizio Zazzi

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Life (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Ilaria VicentiDepartment of Medical Biotechnologies, University of Siena, Viale Bracci, 16, 53100 Siena, Italy.ORCID 0000-0002-4306-2960
Francesca GattiDepartment of Molecular Medicine, University of Padova, Via Gabelli, 63, 35100 Padova, Italy.
Renzo ScaggianteBelluno Hospital, Viale Europa, 22, 32100 Belluno, Italy.
Adele BoccutoDepartment of Medical Biotechnologies, University of Siena, Viale Bracci, 16, 53100 Siena, Italy.
Daniela ZagoDepartment of Molecular Medicine, University of Padova, Via Gabelli, 63, 35100 Padova, Italy.
Monica BassoDepartment of Molecular Medicine, University of Padova, Via Gabelli, 63, 35100 Padova, Italy.
Filippo DragoniDepartment of Medical Biotechnologies, University of Siena, Viale Bracci, 16, 53100 Siena, Italy.ORCID 0000-0002-8148-9914
Saverio Giuseppe ParisiDepartment of Molecular Medicine, University of Padova, Via Gabelli, 63, 35100 Padova, Italy.
Maurizio ZazziDepartment of Medical Biotechnologies, University of Siena, Viale Bracci, 16, 53100 Siena, Italy.ORCID 0000-0002-0344-6281
University of Padua · ITUniversity of Siena · IT

Funding

University of Padova DOR-2019 and DOR-2020
6 · The paper itself

Abstract

We aimed to investigate neutralizing antibody titers (NtAbT) to the P.1 and B.1 SARS-CoV-2 variants in a cohort of healthy health care workers (HCW), including 20 previously infected individuals tested at baseline (BL

Indexed as

B.1 varianthealth care workerslive virus neutralizationneutralizing antibodiesP.1 variantpreviously infected and uninfected subjectsSARS-CoV-2 vaccination

Identifiers

PMID34575045
PMCPMC8470771
OpenAlexW3197301008

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.